- Home
- KYNB vs YSXT Comparison
KYNB vs YSXT Comparison
Compare KYNB & YSXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KYNB | YSXT |
|---|---|---|
| Founded | 1993 | 2011 |
| Country | United States | China |
| Employees | 34 | 38 |
| Industry | Biotechnology: Pharmaceutical Preparations | Automotive Aftermarket |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.1M | 27.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | KYNB | YSXT |
|---|---|---|
| Price | $7.07 | $0.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.1K | ★ 148.9K |
| Earning Date | 05-04-2026 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $0.15 | $5.57 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.32 | $0.50 |
| 52 Week High | $9.58 | $5.01 |
Technical Indicators
Market Signals| Indicator | KYNB | YSXT |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 52.65 |
| Support Level | N/A | $0.98 |
| Resistance Level | N/A | $1.05 |
| Average True Range (ATR) | 0.00 | 0.08 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 0.00 | 79.99 |
Price Performance
Historical ComparisonAbout KYNB Kyntra Bio Inc. Common Stock
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services, and Software Development and Information Technology Services. Key revenue is generated from the Auto Insurance Aftermarket Value-added Services segment, which includes four types of value-added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services, and vehicle maintenance and other value-added services.